Page last updated: 2024-09-04

evodiamine and Brain Ischemia

evodiamine has been researched along with Brain Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, X; Chen, L; Cui, L; Wang, L; Zhang, J; Zhang, L; Zhang, X; Zhao, T; Zhao, X; Zhao, Y	1

Other Studies

1 other study(ies) available for evodiamine and Brain Ischemia

Article	Year
Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3β, down-regulated NF-κB expression, and ameliorated BBB permeability. Neurochemical research, 2014, Volume: 39, Issue:8 Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillary Permeability; Down-Regulation; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Neuroprotective Agents; NF-kappa B; Plant Extracts; Proto-Oncogene Proteins c-akt; Quinazolines; Treatment Outcome; Up-Regulation	2014

Article

Year

Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3β, down-regulated NF-κB expression, and ameliorated BBB permeability.

Neurochemical research, 2014, Volume: 39, Issue:8

Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillary Permeability; Down-Regulation; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Neuroprotective Agents; NF-kappa B; Plant Extracts; Proto-Oncogene Proteins c-akt; Quinazolines; Treatment Outcome; Up-Regulation

2014